Detection of human cytomegalovirus in different histological types of gliomas

Albrecht T, Boldogh I, Fons M, Lee CH, AbuBakar S, Russell JM, Au WW (1989) Cell-activation responses to cytomegalovirus infection relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell Biochem 15:157–202 Albrecht T, Fons MP, Deng CZ, Boldogh I (1997) Increased frequency of specific locus mutation following human cytomegalovirus infection. Virology 230:48–61 Albrecht T, Deng CZ, Abdel-Rahman SZ, Fons M, Cinciripini P, El Zein RA (2004) Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection. Environ Mol Mutagen 43:169–178 Arbustini E, Morbini P, Grasso M, Diegoli M, Fasani R, Porcu E, Banchieri N, Perfetti V, Pederzolli C, Grossi P, Dalla Gasperina D, Martinelli L, Paulli M, Ernst M, Plachter B, Vigano M, Solcia E (1996) Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung. Molecular, immunocytochemical, and histopathologic investigations. Transplantation 61:418–427 Bagasra O, Hansen JA (ed) (2006) In situ PCR techniques. Wiley, New York Bondy ML,Wrensch MR (1996) Epidemiology of primary malignant brain tumours Baillieres. Clin Neurol 5:251–270 Brenner AV, Linet MS, Selker RG, Shapiro WR, Black PM, Fine HA, Inskip PD (2003) Polio vaccination and risk of brain tumors in adults: no apparent association. Cancer Epidemiol Biomarkers Prev 12:177–178 Bresnahan WA, Boldogh I, Thompson EA, Albrecht T (1996) Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:150–160 Britt WJ,Mach M (1996) Human cytomegalovirus glycoproteins. Intervirology 39:401–412 Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350 Docke WD, Kiessling C, Worm M, Friedrich M, Pruss A, Weitz M, Prosch S, Kern F, Volk HD, Sterry W, Asadullah K (2003) Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis. Br J Dermatol 148:954–963 Doniger J, Muralidhar S, Rosenthal LJ (1999) Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev 12:367–382 Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663–667 Hadfield MG, Murray BK, Thomson TA, Young HF (1984) Herpesvirus type 1 serum antibodies and brain tumors in humans. Clin Neuropathol 3:68–71 Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557–1563 Holm R (2005) In situ hybridization methods to study microbial populations and their interactions with human host cells. Methods Microbiol 34:1–25 Howley PM, Ganem D, Kieff E (ed) (2001) DNA Viruses. Lippincott Williams and Wilkins, Philadelphia Huang ES, Roche JK (1978) Cytomegalovirus D.N.A. and adenocarcinoma of the colon: Evidence for latent viral infection. Lancet 1:957–960 Huang G, Yan Q, Wang Z, Chen X, Zhang X, Guo Y, Li JJ (2002) Human cytomegalovirus in neoplastic cells of Epstein–Barr virus negative Hodgkin’s disease. Int J Oncol 21:31–36 Kalejta RF, Shenk T (2002) Manipulation of the cell cycle by human cytomegalovirus. Front Biosci 7:d295–d306 Khalili K, Krynska B, Del Valle L, Katsetos CD, Croul S (1999) Medulloblastomas and the human neurotropic polyomavirus. JC Virus Lancet 353:1152–1153 Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G (1998) High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 26:1076–1082 Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838–843 Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK (1999) Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 2:91–101 Martin JD, King DM, Slauch JM, Frisque RJ (1985) Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 53:306–311 Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 1:10–18 Ohagen A, Gibaja V, Horrigan J, Lunderville D, Jayarama V, Marcello J, Chapman J, Lazo A (2004) Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110. Vox Sang 87:1–9 Onorato IM, Morens DM, Martone WJ, Stansfield SK (1985) Epidemiology of cytomegaloviral infections: recommendations for prevention and control. Rev Infect Dis 7:479–497 Piña-Oviedo S, De León-Bojorge B, Cuesta-Mejías T, White MK, Ortiz-Hidalgo C, Khalili K, Del Valle L (2006) Glioblastoma multiforme with small cell neuronal-like component: association with human neurotropic JC virus. Acta Neuropathol 111(4):388–96 Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90–99 Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D (1996) Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci USA 93:7352–7357 Sabatier J, Uro-Coste E, Benouaich A, Boetto S, Gigaud M, Tremoulet M, Delisle MB, Galateau-Salle F, Brousset P (2005) Immunodetection of SV40 large T antigen in human central nervous system tumours. J Clin Pathol 58:429–431 Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, Delisle MB, Brousset P (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747–750 Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998–1002 Sanford EJ, Geder L, Laychock A, Rohner TJ, Rapp F (1977) Evidence for the association of cytomegalovirus with carcinoma of the prostate. J Urol 118:789–792 Scheurer ME, Lopez MS, Chrisman K, Albrecht T, Bondy ML, El-Zein R (2007) Effects of Human cytomegalovirus infection on radiation-induced cytogenetic damage in peripheral blood lymphocytes from a glioma case-control study. In: American Association of Cancer Research Annual meeting Shen Y, Zhu H, Shenk T (1997) Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA 94:3341–3345 Soderberg-Naucler C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259:219–246 Weller TH (1971) The cytomegaloviruses: ubiquitous agents with protean clinical manifestations II. N Engl J Med 285:267–274 Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M (1997) Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol 145:594–597 Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K (2001) Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 154:161–165